FDA PCAC reviews 7 peptides in July. Read →

PeptideXpo

Survodutide

GLP-1 / glucagon dual receptor agonist (BI 456906)

≥ 99.0%CAS 2365457-03-9Metabolic & GLP-1

Overview

Survodutide (BI 456906) is an investigational GLP-1 / glucagon dual receptor co-agonist for metabolic research applications.

Specifications

CAS
2365457-03-9
Purity (HPLC)
≥ 99.0%
Common vial sizes
10 mg
MOQ
On request
Lead time
14–21 days
Storage
-20°C, protect from light

Documentation available on request

  • Certificate of Analysis (COA)
  • HPLC Chromatogram
  • Mass-spec spectrum
  • Stability data
  • SDS / MSDS
  • Sequence verification

Regulatory note

Investigational compound; supplied for research use only. CAS commonly cited but should be verified per batch COA.